Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-30

Clinical Trial Update: RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of RAFT for aniridia-related keratopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RAFT

Snippet

Sponsor: University College, London | Conditions: Aniridia | Phase 1, Phase 2 | Status: COMPLETED